NDC 73604-914 – Arcalyst

Rilonacept 160 mg/2mL · Injection, Powder, Lyophilized, For Solution · Subcutaneous

Human Prescription Drug

Product NDC73604-914

Product details

Brand name
Arcalyst
Generic name
Rilonacept
Labeler
Kiniksa Pharmaceuticals (UK), Ltd.
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Subcutaneous
Marketing category
BLA · BLA125249
Marketed since
February 27, 2008
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Arcalyst →

Package NDC codes (2)

Package NDCDescriptionSince
73604-914-011 VIAL, SINGLE-USE in 1 CARTON (73604-914-01) / 2 mL in 1 VIAL, SINGLE-USEJun 18, 2021
73604-914-044 VIAL, SINGLE-USE in 1 CARTON (73604-914-04) / 2 mL in 1 VIAL, SINGLE-USEMar 24, 2008